The funding will support the launch of the VERITAS trial while strengthening the company's clinical and regulatory ...

Field Medical announced today that it has closed a Series B funding round worth proceeds totaling $35 million.

BioStar Capital and Cue Growth co-lead financing to accelerate pivotal trial readiness and expand the ventricular tachycardia ...

Scientist and teacher releases book summarizing his field of research from the last 25 years BALTIMORE, Nov. 4, 2024 /PRNewswire-PRWeb/ -- Author Victor Frenkel, PhD, has published his new popular ...

--PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis ...

Modern technology is transforming the rehabilitation process from routine to fun. The use of gaming apps and virtual reality helps patients recover faster by combining therapeutic exercises with ...

Helius Medical Technologies, Inc. Announces Claim Authorization by CignaHealth, for its Portable Neuromodulation Stimulator (PoNS®) Device Provided by GlobeNewswire Jun 16, 2025, 11:00:00 AM ...

Helius Medical Technologies, Inc. (Nasdaq:HSDT) ("Helius" or the "Company"), a neurotech company focused on delivering a novel therapeutic neuromodulation ...

Biomedical engineering is a field that employs quantitative methods in physics, chemistry and biology to develop innovative medical technologies. Skip to main content . Search. Enter the terms you ...

In the interdisciplinary field of medicine and materials science, a recent breakthrough by Professor Jianlin Shi's team is revolutionizing antibacterial therapy. They have successfully developed a ...

Panelists discuss how recent advancements in muscular dystrophy treatment have evolved toward truly disease-modifying therapies using gene replacement, antisense oligonucleotides, and gene ...

Detailed price information for Helius Medical Technologies Inc (HSDT-Q) from The Globe and Mail including charting and trades.